category
NAR
date
Feb 28, 2026
slug
status
Published
summary
首次解析Type I-F2系统Cascade-Cas3复合物的冷冻电镜结构,揭示Cas5独立完成PAM识别、Cas7直接招募Cas3的新型机制,阐明无Cas8/Cas11亚基情况下通过Cas3构象变化实现DNA解旋降解的分子基础,为超紧凑型CRISPR系统工程化改造提供结构依据。
tags
基因编辑
核酸蛋白工具酶
type
Post
📄 原文题目
Structural basis of Cas8-independent Cas3 recruitment in Type I-F2 CRISPR–Cas
🔗 原文链接
💡 AI 核心解读
首次解析Type I-F2系统Cascade-Cas3复合物的冷冻电镜结构,揭示Cas5独立完成PAM识别、Cas7直接招募Cas3的新型机制,阐明无Cas8/Cas11亚基情况下通过Cas3构象变化实现DNA解旋降解的分子基础,为超紧凑型CRISPR系统工程化改造提供结构依据。
📝 英文原版摘要
<span class="paragraphSection"><div class="boxTitle">Abstract</div>CRISPR–Cas systems provide adaptive immunity in prokaryotes by targeting and degrading invasive genetic elements. Among them, the Type I-F2 system represents the most compact Type I CRISPR–Cas variant, distinguished by the complete absence of both large (Cas8) and small (Cas11) subunits. In other Type I systems, Cas8 is essential for protospacer adjacent motif (PAM) recognition and for triggering Cas3 recruitment, while Cas11 stabilizes the Cascade backbone and guides the nontarget DNA strand during R-loop formation. To elucidate how I-F2 executes interference in their absence, we determined the cryo-electron microscopy structure of the I-F2 Cascade bound to target DNA and Cas3. Our structure reveals that Cas5 alone mediates PAM sensing, while Cas7 subunits directly recruit Cas3, which adopts a helicase-loaded conformation compatible with DNA engagement. We show how the helicase and C-terminal domains of Cas3 capture the displaced nontarget strand to initiate directional unwinding and degradation. These findings uncover key mechanistic adaptations that enable efficient interference without canonical large and small subunits and emphasize the mechanistic diversity among closely related Type I systems, including I-E, I-F1, and I-F2. These insights provide a structural basis for engineering the hypercompact I-F2 system for genome editing and biotechnological applications.</span>
- 作者:NotionNext
- 链接:https://tangly1024.com/article/31548bd6-1f96-812c-8ac0-d9c3b098eefb
- 声明:本文采用 CC BY-NC-SA 4.0 许可协议,转载请注明出处。
相关文章
